News Agency
Men's Weekly

Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and Androgenic Alopecia

  • Written by PR Newswire
  • Chime Biologics to support the late-stage clinical study and to provide global commercial manufacturing services for Hope Medicine's first-in-class monoclonal antibody drug, HMI-115.
  • The first-in-class mAb will benefit endometriosis and androgenetic alopecia patients.

SHANGHAI, Oct. 26, 2023 /PRNewswire/ -- Chime Biologics, a...

Read more: Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of...

Improving Internal Feedback Loops Through CMS-Based Commenting and Versioning

Collaboration is essential for successful digital content creation. Unfortunately, in many companies, the feedback mechanism between marketing, design, product and development functions is less than cohesive. For example, feedback is left in email chains, instant chat messages, or within locked... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion